IGF1 and hepatocellular carcinoma: Since clinical outcomes vary considerably depending on the etiology of HCC[22–24] and, globally, HBV is the most common cause of HCC,[25] it is essential to validate the IGF-CTP classification in CHB endemic areas prior to the widespread application of the new classification system.